Skip to main content
. 2019 Oct 29;11(5):886–894. doi: 10.1111/os.12542

Table 1.

Characteristics of the patients at baseline

Characteristics Aspirin (n = 198) Rivaroxaban (n = 192) P‐value
Age ‐ yr. 69.4 ± 17.4 67.8 ± 16.9 0.96
Male ‐ no. (%) 99 (50.0) 91(47.7) 0.61
Body mass index (kg/m2) 23.5 ± 2.4 23.7 ± 2.8 0.08
Fracture site
Femoral neck fracture ‐ no. (%) 72(36.3) 69(35.9) 0.93
Intertrochanteric fracture of the femur ‐ no. (%) 126(63.6) 123(64.1)
Surgery waiting time ‐ d 4.8 ± 1.7 5.5 ± 1.8 0.50
Type of surgery
Three hollow screws ‐ no. (%) 23(11.6) 27(14.1) 0.67
PFNA or sliding hip screws ‐no. (%) 126(63.6) 123(64.1)
Hemi‐arthroplasty ‐ no. (%) 49(24.7) 42(21.9)
Time in operation room ‐ hr. 1.36 ± 0.33 1.40 ± 0.34 0.73
Estimated blood loss ‐ ml 98.5 ± 60.6 101.2 ± 57.5 0.94
Combined disease
Type 2 diabetes ‐ no. (%) 17(8.6) 11(5.7) 0.50
COPD ‐ no. (%) 12(6.1) 13(6.8)
Coronary heart disease ‐ no. (%) 2(1) 0
Hypertension ‐ no. (%) 24(12.1) 22(11.5)
Length of hospital stay ‐ d 21.7 ± 12.5 19.8 ± 8.1 0.09